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ABSTRACT 
 
SANDI JEANNE LANE. The association of structural and process factors with 
medication errors for residents entering a nursing home. (Under the direction of DR. 
JACQUELINE DIENEMANN and DR. JENNIFER TROYER) 
 
 Objective: The purpose of the study is to elucidate the relationships and inter-
relatedness of specific structure, process, and outcome elements contributing to harmful 
medication errors for the vulnerable people who reside in nursing homes by exploring the 
inter-relationships between structure and process factors in relationship to medication 
errors and medication errors associated with harm. 
 Methods: The Medication Error Quality Initiative-Individual Error (MEQI-IE) 
Data for North Carolina nursing homes for FY 2007 was used for analysis. A 
multivariable model was used which controlled for facility and resident charateristics, 
phases of the medication use process, reported causes of the error, primary type of error, 
personnel involved, and number of medications. 
 Results: Ownership status does not directly impact the number of medication 
errors reported or a more harmful error being reported. Chain affiliation was found to 
interact with ownership status; a not-for-profit nursing home that is a member of a chain 
is predicted to have half the rate of medication errors that a for-profit nursing home t at is 
not part of a chain has. Prescribing errors are associated with harm more often than 
administering errors during the medication use process; and a dose omission error is less 
likely to be associated with harm than a wrong dose error. 
 Conclusions: Over two-thirds of the nursing homes reported a medication error 
during the first seven days of a resident's admission. Chain affiliation interacts with 
ownership status and is associated with a decrease in incidence rate of reported 
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medication errors. Medication errors during the administration phase account for o e 
third of the errors, but prescribing errors, which account for only 4.8% of all errors, are 
associated with more harmful events. Wrong dose errors are associated with harm twice 
as often as dose omissions even though dose omissions were reported in over one third of 
the errors. Almost one half of the wrong dose errors occurred during the documenting 
phase with 42.7% a recording issue. The processes surrounding and related to 
documentation and recording of the medication use process are critical to medication 
safety for residents during their first seven days of admission into the SNF.  
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CHAPTER 1: INTRODUCTION 
 
 
Specific Aims 
 Older adults are especially susceptible to adverse drug events due to their frail 
condition, multiple physical and cognitive aliments, complex drug regimens and frequent 
transitions throughout the health care continuum. Documented adverse drug events with 
individuals 65 years of age or more were 25.3% of all emergency department visits. Of 
those adverse drug events requiring hospitalization, 48.9% involved those 65 and older1. 
Brennan et al. reported that residents 65 or older had greater than twice the risk of an 
adverse drug event than residents 16-44 years of age2. 
 These findings are of added importance as older persons, those age 65 and over, 
are a growing proportion of our population. Population projections indicate that in 2010, 
13% of the US population will be 65 and older and by 2050 this will increase to 20%3. Of 
the almost 1.5 million people living in nursing homes in 2004, 1.3 million were over 65 
years of age with women out numbering men two to one; 174,100 of the 1.3 million were 
65-74, 468,700 were aged 75-84, and 674,500 were over 85 years of age4.  
 Many of those aged 65 and over will have at least one nursing home admission. 
The five leading nursing home admission diagnosis were diseases of the circulatory 
system (23.7%), mental disorders (20.6%), diseases of the nervous system and sense 
organs (14%), Alzheimer's disease (8.5%), and heart disease (8.3%)5. A nursing home is 
a long-term care facility certified by Medicare and Medicaid that provides skilled nursing
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 services, often times referred to as a skilled nursing facility (SNF).  
 Considerable research and attention has been focused on medication errors in the 
acute care setting, much less effort has been focused on errors in long-term care settings. 
Yet, North Carolina SNFs report 13,551-15,145 medication errors and potential 
medication errors (circumstances or events that have the capacity to cause an error6) each 
year7-9. More importantly, studies estimate that approximately 800,000 preventable 
adverse drug events occur in U.S. long-term care facilities annually with an estimated 
350,000 in SNFs10. 
 Studies of medication errors in SNFs have identified the transition period at initial 
admission, re-admission after a hospitalization or when changing medical providers as 
particularly risk prone11, 12. Upwards of 46% of medication errors occurred during 
transition between levels of care or providers, a time when orders are frequently updated 
and changed13. This period is vulnerable to medication errors primarily due to poor 
communication between care teams14-16. 
Consideration of resident level medication error data in the context of a modified 
Donabedian model of structure, process, and outcome (SPO) would provide an 
opportunity to evaluate the degree of adjacent interactions, as well as the proportion of 
root causes of errors due to structure, process or the interaction between the two. For 
example, although structure can impact process and directly impact outcome, it does not 
ensure specific processes take place nor specific outcomes occur.  
Previous nursing home research using the structure variable of profit status found 
that for-profit SNFs provide lower quality care17-23. This study will examine if this results 
in residents in for-profit SNFs experiencing more medication errors and more edication 
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errors associated with harm than residents in not-for-profit SNFs using a cross sectional 
analysis of medication errors from North Carolina.  
Hypothesis 1a:  For-profit nursing homes will report a higher rate of medication errors 
during the seven days following admission than not-for-profit nursing homes.    
Hypothesis 1b:  A harmful medication error is more likely to be reported by a for-profit 
nursing home than not-for-profit nursing home during the seven days following 
admission.    
 Previous nursing home studies of process variables include adequacy of care 
plans, use of restraints24, 25, urinary catheters26, 27, feeding tubes28 and the medication use 
process29-31. Studies of medication errors during the various phases of the medication use 
process indicate variable results regarding the relationships between proc ss measures 
and medication errors. However, several studies indicate that 34-55 % of the errors 
occurred during administration of the medication use phase8, 9, 29-31.  
Hypothesis 2:  Medication errors are more likely to be harmful when administering is 
reported as the medication use phase compared to any other phase in the medication use 
process during the seven days following admission.  
 Studies of the primary medication error type indicate dose omission is often the 
primary error type (23%-53% of errors), often followed by wrong dose (7%-21% of 
errors)8, 29-31. We theorize that wrong dose (under dose or over dose) is more likely to do 
harm than omitting a dose or other type of medication error.  
Hypothesis 3: Medication errors are more likely to be harmful when wrong dose is 
reported as the error type compared to any other type of error during the seven days 
following admission. 
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The purpose of the study is to elucidate the relationships and inter-relatedness of 
specific SPO elements contributing to harmful medication errors for the vulnerab e 
people who reside in SNFs. Toward this end, this study will explore the inter-
relationships between structure and process factors in relationship to medication errors 
and medication errors associated with harm. These findings, it is hoped, will contribute to 
identification of opportunities for improvements in systematic processes of medication 
use. For many of these residents an adverse drug event contributes to a downward 
cascade of health, making prevention of the utmost importance32, 33.   
 
 
 
 
   
 
 
 
 
 
 
 
CHAPTER 2: LITERATURE REVIEW 
 
  
Background and Significance 
 
  The Institute of Medicine defines a medical error as “the failure of a planned 
action to be completed as intended (i.e, error of execution) or the use of a wrong plan to 
achieve an aim (i.e, error of planning)”34. Medical errors may cause injury and may also 
result in costly medical care and human suffering. Adverse events are limited to when 
injury occurs from a medical error or there is an idiopathic patient response that is
harmful. Brennan and associates defined adverse events as an injury caused by medical 
management as opposed to the disease process 2.  
 Previous studies of medication safety and adverse drug events in SNFs have 
evaluated the prevalence of medication errors, use of inappropriate medications for the 
older adults 35-38, categories of medications involved10, 33, 39-41, contributing risk factors10, 
39, 42-46, impact of monitoring and medication reconciliation programs39, 42, 47, and adverse 
drug events during resident transfers between hospitals and nursing homes.  
 Using data from the 1996 Medical Expenditure Panel Survey Nursing Home 
Component, Lau et al. reported at least 50% of all residents aged 65 and older received at 
least one potentially inappropriate medication during a three month nursing home stay 38. 
The criteria used most often to assess medication appropriateness was published by Be rs 
and colleagues in 1991 and updated in 1997 48, 49. Beers himself reported 40% of 
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residents in nursing homes received at least one potentially inappropriate medication 50. 
A study conducted in 15 Georgia nursing homes identified 519 (46.5%) patients received 
at least one inappropriate medication and 143 experienced an adverse health outcome 51. 
A study of inappropriate prescribing before and after nursing home admission found 
residents receiving at least one inappropriate drug decreased from 25.4% before 
admission to 20.8% after admission 35. Nursing homes reporting potentially inappropriate 
medications among their 10 most common medication errors also reported a greater 
number of medication errors 41.  
 Medication error and adverse drug event studies in nursing homes report 
conflicting findings for the most prevalent drugs and drug classes involved in medication 
errors. North Carolina nursing homes reported warfarin, horazepam, insulin, and 
hydrocodone as the drugs most frequently involved as medication errors for the four year 
period 2004-20078, 52. Two recent (2001 & 2003)  studies report similar findings of 
central nervous system, anticoagulants, and electrolytic, caloric and water bal nce gents, 
drugs as the most prevalent class of drugs involved in adverse drug events or medication 
errors 10, 29. Whereas, findings from earlier (1991-1995, 1988-1989)  studies identified 
cardiovascular drugs and central nervous system drugs as the most frequently repor ed 43, 
46, 47. Another study reported diuretics and anticoagulants as the drug categories most 
frequently involved in adverse drug events 42. Differences in data collection methods and 
year when the study occurred contribute to the variation in the most prevalent class 
reported. The earlier studies used chart reviews whereas, the more recent studies 
interviewed staff in addition to chart reviews. Substantial changes in pharmaceutic l 
7 
 
 
 
regimes and new drug development along with increased resident acuity also contribute 
to the differences in study results. 
 Studies of risk factors contributing to a medication error or adverse drug event 
pinpoint a number of potential risk factors. For instance, an early study identified age, 
being female and an increase in the number of medications as risk factors for an adverse
drug event 47; few other subsequent studies found age or gender to be risk factors 42-46. 
Many studies identified an increase in the number of medications or medications from 
multiple drug classes 10, 43-47, an increase in the number of medical diagnoses 45, 46, being 
a new resident 44 or recently hospitalized 46, and having experienced a prior adverse drug 
event 45 as risk factors. Gurwitz et al. identified several drug categories as rik factors for 
adverse drug events; antipsychotic agents, anticoagulants, diuretics, and antiepileptics 10. 
 Programs to monitor and reduce adverse drug events indicate their benefit. Soon 
(1985) implemented a two phase program involving pharmacist medical record review, 
staff education, and physician communication resulting in fewer drug reactions and fewer 
residents experiencing more than one reaction. The author attributes the reductions to the 
education and monitoring program. A multidisciplinary monitoring program 
implemented in a 465 bed not-for-profit SNF increased the number of adverse drug 
reactions documented from 21 to 216 in an eighteen month period 42. Boockvar et al 
studied the effect of medication reconciliation on return to the nursing home from an 
acute care stay. The odds of having an adverse drug event were significantly reduced 
after implementation of medication reconciliation 53. To improve communication of 
patient-specific information for new SNF admissions, a group of medical directors 
implemented a multi-facility communication system which improved the flow of inter-
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facility information54.  Various uses of information technology in acute care indicate 
benefit in the reduction of medication errors and adverse drug events in long term car 55, 
including; computerized physician order entry56-58, on-line decision support systems59, 
alert and warning systems for allergies or drug interactions60, and automating the 
prescribing process61. 
  The transfer process between hospitals and SNFs has been identified as a time of 
increased risk of an adverse drug event. Field et al. (2001) reported that being a newly 
admitted resident increased the odds of an adverse drug event by 2.8 (95% CI 1.5-5.2)44, 
Gerety et al. (1993) reported similar findings in that hospitalization during the study 
period was strongly correlated with adverse drug event incidence46. Boockvar et al. 
(2004) studied the iatrogenic harm from medication changes during resident transfer and 
identified an overall risk of adverse drug event per drug changed to be 4.4%62.  
 Studies of medication error and adverse drug event often employ varying methods 
of error detection due to the variability of error occurrence, differences i  definitions, 
complexity of the medication use process (e.g. administering errors are detecte  via 
observation whereas prescribing errors are detected through chart review), and outcome 
being measured63. The chart review method has been used in several research studies 
including the landmark Harvard Medical Practice Studies I2 and II64, Thomas's  study of 
negligent care in Utah and Colorado65, and many studies smaller in scope1, 66. Chart 
reviews entail retrospective data collection by trained data collectors. In addition to chart 
reviews other documents such as incident reports and pharmacy logs are review d for 
potential identification of an error or adverse event. Review of submitted incident repor s 
has also been used to evaluate medication error and adverse drug event. MEDMARX is a 
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voluntary, anonymous, confidential database owned by United States Pharmacopeia 
where member hospitals report medication errors and can track and share medication 
error data with other providers in a standardized format. Santell et al. used this me od in 
his analysis of reported medication errors30, 31 . A third error detection method, 
observation, is reported to best estimate the true frequency of medication errors 
especially administration errors67. Direct observation entails the observation of 
preparation and administration of medication to the patient. The observer then compares 
the dose given to the dose ordered, if there is a difference an error is noted68. One study 
reported that of the 318 medication errors reported using direct observation only 1 was 
detected by an error report67. Studies indicate that underreporting of medication errors 
has been identified as a significant barrier to improving safety. Osborne et al. reported 
that nurses believed only 3.5% of medication error are ever reported69. Other studies 
indicate that fear of disciplinary action and job loss are the primary reasons for not
reporting an error69-73.  
 Some researchers use multiple methods to optimize the identification and 
collection of medication errors and adverse drug events. For example, Bates et al u ed 
incident reports, voluntary verbal reporting by staff to the researcher, and chart reviews to 
identify adverse drug events and potential adverse drug events. They identifie 247 
adverse drug events and 194 potential adverse drug events out of 4031 admissions to 11 
hospital units over six months74. 
 Studies of medication errors during the medication use process indicate variable 
results, finding errors are most frequent during prescribing or administering phases of the 
process. Bates et al. reported that the phase of medication use where the most adverse 
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drug events occur for hospitalized patients is during ordering (49%) and administering 
(26%)74, whereas Santell reported 15%  and 6% of medication errors occurred during 
prescribing, and 37% and 55% during administering in his 2003 and 2005 studies of 
hospitalized adults over the age of 65 respectively30, 31. Prescribing often occurs during 
transition as new orders are communicated to the transitioning care team75. Gurwitz in his 
study of two academic long-term care facilities found that 59% of the adverse drug vents 
occurred during ordering (prescribing)10. In his study of 18 community based 
Massachusetts nursing homes 68% of the preventable errors occurred during orderingand 
only 3% during administering33. North Carolina nursing homes reported approximately 
55% of the reported errors occurred during administering, 30% during documentation, 
and less than 5% during prescribing over a four year mandatory reporting period (2004-
2007)9.   
 Differences in reports of where an error is identified in the medication use proc ss 
could be attributable to the medication error and adverse drug event detection method 
used in the study or the outcome being examined. Gurwitz et al. used chart reviews by 
pharmacists and nurses and prompted self reporting (via interviews with nursing staff), in 
both of his studies to identify adverse drug events. Incident reports were also used in his 
study of the two academic long-term care facilities, making the adverse drug event 
detection method similar to that used by Bates et al. Gurwitz et al. and Bates et l. 
reported more adverse drug events occurred during the prescribing phase of the 
medication use process. Studies examining medication errors versus adverse drug events 
may report different findings of the same data set. For example, Leape et al examined the 
number of errors that occurred in 4031 adult admissions in two medical and surgical units 
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using chart reviews and identified 334 errors of which 39% of the errors occurred during 
physician ordering and 38% of the errors occurred during nurse administration of the 
drug66. Bates et al examined the same data assessing the incidence of adverse drug ev nts 
and reported 56% of the events occurred during ordering and 34% during administration 
of the drug. Differences in detection methods and outcomes being measured may 
contribute to variations in the findings. Santell reported medication errors of older adults 
using MEDMARX data, a national voluntary medication error program. This program 
allows participating hospitals to report medication errors to a national database using 
standard taxonomy. Standardization of reporting elements allows for evaluation of errors 
across multiple facilities. Studies using medication errors from self-reported errors versus 
studies using onsite chart reviews, observations and interaction with staff  may account 
for the difference in the number of medication errors reported as originating in the
administering versus prescribing phase 30, 31.  North Carolina mandates reporting of all 
medication errors and potential medication errors by nursing homes to the Medication 
Error Quality Initiative (MEQI) database9. MEQI is similar to the MEDMARX database 
in that medication errors are self-reported; different in that MEQI is mandatory reporting 
and MEDMARX is voluntary. These self-reported adverse drug event studies indicate 
administering the drug as the primary phase where the error was first identifie .   
 Studies of the primary type of medication error indicate varying results. Dose
omission is often reported as the most frequent type of error reported (23% to 53% of the 
errors reported)9, 30, 68, with wrong dose following at a rate of (7% to 21%)9, 30, 68. 
Handler, in a 21 month study in one long term care facility, reported problems with 
documentation (interpreting and updating the medication administration record) as the 
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most prevalent among 98 medication errors with 27 occurrences, and delay in medication 
administration as a close second with 26 occurrences, wrong dose was reported 17 
times29. Whereas Santell reported prescribing errors (10%), wrong administration 
technique (7%), wrong route (6%), and wrong dose (5%) as the primary error types in 
errors that caused harm in hospitalized older adults using a national voluntary error 
reporting database31. Differences in study populations contribute to the variation in 
findings.  
 Studies of perceptions and concerns with the medication process among nurses in 
nursing homes indicate underreporting of medication errors by nurses29, 76, 77. Several 
barriers exist deterring the reporting of errors including fear of discipl nary and punitive 
action29, feelings of shame or inadequacy75, and cumbersome reporting systems78. Nurses 
surveyed in a pediatric unit believed that the stage in the medication use process where 
the error occurred is associated with completing an error report. Errors later in the 
process (i.e. administering the drug) are more likely to be reported than prescribing 
errors79. Nursing home nurses reported 60 administration errors out of 88 medication 
error reports, and felt that the majority of medication errors occurred at this stage of the 
medication use process29, findings similar to that of the pediatric nurses. One qualitative 
study of nurses' perceptions of the medication use process indicated common themes 
related to the complexity of the administration phase, concerns with the timeliness a d 
accuracy of medication administration, and accuracy of the medication administration 
record76. The concerns identified by the nurses contribute to deeper understanding of how 
errors such as wrong time, wrong dose, and doses omitted became the prevalent 
medication errors noted. 
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 Although identified as a time of high risk for medication errors, few studies have 
examined adverse drug events and medication errors for residents transferring to SNFs. 
Thus, it is useful to evaluate how resident, staff, and facility characteristics are associated 
with medication errors, and adverse events due to medication errors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3: DESIGN AND METHODS 
 
 
3.1 Conceptual Framework  
 The literature is replete with research utilizing Donabedian’s (1966) framework 
for analyzing quality in health care settings80. The interacting elements of structure, 
process and outcome have been systematically employed to describe and summarize the 
various dimensions of quality. In SNFs, structure refers to the characteristi s of he 
institution and its infrastructure; process variables are the actions and procedu es 
completed for and to the resident by staff; and health outcomes are the resultant changes 
in the resident physiologically, cognitively or functionally. Use of this framework in 
nursing homes often employs the structure variables of: location of nursing home (rural, 
urban), ownership (chain, independent), profit status (for-profit, not-for-profit), staffing 
(number and type), and size (number of beds). Examples of process variables studied 
include: use of restraints, catheters, medication use process, and use of medication 
reconciliation. Outcome indicators of quality previously studied include: development of 
pressure ulcers81, frequency and harm of falls25, 82-84, weight loss85, adverse drug events1, 
10, 33, 86, 87, and mortality1, 10, 88.  
 Donabedian’s framework implies that when structural characteristics that upport 
quality processes are in place, improved processes can be implemented producing better 
outcomes. The true interrelationship between structure and process is not simple nor 
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linear89. Atchely (1991) proposed that the model is a time-ordered process with outcomes 
and processes feeding back to structural components and process actions90. Having the 
appropriate structural components and providing the appropriate care influences 
outcomes. The outcomes observed provide feedback to the processes and structures 
influencing change or refinement of the system. 
Other research discusses the causal linkages and relationship between structure, 
process and outcomes by dividing the structural factors into two components, those under 
management’s control (mutable) and those characteristics not likely to be changed or 
altered by management (immutable)91, 92. Studies have evaluated the impact of the 
immutable characteristics on the amount and type of nursing staff82, 93-95. While others 
have evaluated immutable characteristics in relation to nursing processes such as restraint 
use24, 25, 27. Studies of structural characteristics such as ownership and number of beds and 
resident outcomes are numerous18, 19, 27, 82, 84, 96. Although Hillmer et al. (2005) in their 
systematic review of the literature state that the most common structure variable used in 
evaluating nursing home quality is staffing97. 
Studies assessing the impact of nurse staffing levels on quality outcomes indicate 
lower staff to resident ratios decreased quality and increased the prevalenc  of 
deficiencies19, 97, 98. Deficiencies are formally recognized departures in practice from state 
and federal guidelines by nursing homes in the provision of care (i.e. restraint use, 
development of pressure ulcers, and weight loss).  
Process measures reflect the quality of care provided to residents in nursing 
homes and therefore are often used as indicators of nursing home quality97. Assessing 
organizational processes (such as restraint or urinary catheter use) determine which care 
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processes contribute to variation in an outcome such as development of a decubitus ulcer 
or urinary tract infection. Processes of care often are more able to identify smaller 
variations in quality than structure characteristics89. Additionally, processes can often be 
changed when needed, but structure cannot easily be changed. For example, it is much 
easier to change a policy or procedure for restraint or catheter use than it is to change the 
ownership or affiliation with a chain. 
Studies have evaluated relationships between structural variables such as 
ownership21, 83, 85, 99, 100, chain membership21, 83, 85, 99, size21, 83, 85, payer mix or payer 
type21, 83, 101, 102, and staffing with outcomes such as quality indicators with varying 
results. For-profit long-term care facilities were found to hospitalize their residents 
suspected of pneumonia two times more often than not-for-profit facilities102,  increase 
restraint use by 20%83, have 1.2 times more survey deficiencies, and have a higher total 
(25% ) number of F-plus survey deficiencies 21 (defined as potential or actual harm 
occurred for at least one resident) than not-for-profit facilities. Chain-ownership was 
found to increase restraint use (31% increase)83 and number of survey deficiencies21, 103. 
Facility size produced varying effects in differences in outcomes, for example, restraint 
use decreased by 5% for every ten bed increase in nursing home size83, whereas number 
of beds was not determined to contribute to higher numbers of deficiencies or F-plus 
deficiences21. Amirkhanyan and associates reported that as number of beds increased, 
for-profit facilities had significantly more deficiencies 103. Studies evaluating staffing as a 
structural variable and quality outcomes indicate facilities with more Registered Nurse 
(RN) full time equivalents (FTE) per 100 beds are less likely to increase straint use, 
while facilities with more nurse aides per 100 beds are more likely to increase straint 
17 
 
 
 
use83; facilities with an average increase of 1.17  Registered Nurses per 100 residents are 
likely to receive two less deficiencies101; and hospital based facilities with an increase in 
professional staffing were less likely to transfer a resident for pneumonia102. Calculations 
of nursing staff hours (nursing staff hours equals RN, licensed practical nurse (LPN) and 
certified nursing assistant (CNA) hours combined) per patient day in North Carolina 
nursing homes using the 2007 Nursing Home Compare - About Nursing Homes and 
About Nursing Home Staff data indicate for-profit nursing homes staff on average 3.63 
nursing hours per resident day whereas not-for-profit homes staffed 4.86 nursing hours 
per resident day (p< .0001)104.  
 Process variables of the Donabedian model have been studied less frequently than 
structure. Some researchers indicate that process is more difficult to measure105 and that 
the elements used to measure structure and process contain aspects of both therefre
blurring the lines of distinction between structure and process17. Process components 
studied include assessment of resident status, adequacy of the care plan, use of 
restraints24, 25, 27, 82-84, urinary catheters26, 27, and feeding tubes28, use of psychoactive 
medications26, 106-109, and the development and treatment of pressure ulcers110.  
 Most studies of quality in nursing homes are based on survey deficiency data and 
quality indicators obtained from the On-line Survey, Certification and Reporting 
(OSCAR) system and the resident based assessment tool the Minimum Data Set (MD ), 
respectively. These federally mandated data sets contain assessment of residents function 
and health. The MDS requires a resident assessment be completed on a systematic basis 
depending upon resident changes and clinical needs as a requirement to receive Medicare 
or Medicaid payment for eligible residents. OSCAR data is a compilation of facility 
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characteristics, aggregate resident health status, and reported deficienci s. Various studies 
of resident outcomes such as pressure ulcers, incontinence, quality of life and resident 
behavior have been assessed using both OSCAR and MDS data. Medication errors and 
potential medication errors are not recorded in the MDS or OSCAR. Therefore studi s of 
quality indicators using the MDS and OSCAR do not contain medication errors in their 
measures.  
 Studies of medication errors are fewer and have been dependent on chart reviews,
interviews, observations, and voluntary reporting. Beginning January 2004, North 
Carolina Senate Bill 1016 mandated that all nursing homes licensed by North Carolina 
Department of Health and Human Services report all actual and potential medication 
errors. The database for collection of the errors is the nursing home Medication Error 
Quality Initiative (MEQI). Nursing homes reported medication errors and potential errors 
for the first three years of MEQI implementation using annual reporting. During year 
three individual error reporting was piloted in 23 facilities. Reporting year four (October 
1, 2006 - September 30, 2007) provided the option to report errors using the individual 
error reporting system: 203 of the 393 SNFs opted to use the individual error system. 
 In the review of the literature no studies were identified that examined medication 
safety or medication errors using a modified Donabedian model during transition into the 
nursing home, suggesting an important gap in the literature. The conceptual model for 
this study is shown as Figure 1 (Appendix: A). The structure variable Profit status 
directly and indirectly impacts the outcome of harm from medication errors; directly as 
investigated with Hypothesis 1, and indirectly with Hypothesis 2 and Hypothesis 3. Profit 
status of a nursing home may determine the operational perspective relative to efficiency 
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and use of resources to provide care. The difference in nurse staff levels between for-
profit and not-for-profit nursing homes in North Carolina supports this perspective. 
Previous research has linked profit status and chain affiliation and has shown that for-
profit facilities are often members of a chain. In North Carolina 77% of for-profit nursing 
homes are chain affiliated whereas only 46% of not-for-profit nursing homes are chain 
affiliated104. 
 The medication use process is a complex highly regulated nursing process. 
Considerable focus is placed on the administering phase as a means to optimize safety 
due to the multiple steps in the delivery of medication. Errors that occur during 
prescribing, dispensing, documenting and monitoring provide opportunities for error 
detection before reaching the patient due to reviews by pharmacists or other nurses. I  
contrast there is less opportunity to detect an error during administration as this typically 
is an independent task. Regulations abound for the delivery of medications from an array 
of agencies, including Centers for Medicare and Medicaid Services (CMS), Joint 
Commission on Accreditation of Healthcare Organizations (JCAHO), state agencies 
responsible for SNF inspections, and Boards of Nursing, to name a few. During the 
nursing home annual on-site visit by state agencies, a medication pass observation is 
required. From the observation of medications administered, an error rate is calculated, if 
greater than 5% a deficiency is issued. Previous research indicates that most medication 
errors in older adults occur during the administration phase. Leading to the question, do 
more harmful outcomes occur from medication errors during the administering phase of 
the medication use process than any other phase?  
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3.2 Data 
The MEQI Data for North Carolina nursing homes for FY 2007 was the primary 
data source used. An observational case series design was used to evaluate the 
relationship between variables. The data set contains facility self-reported medication 
errors mandated by state legislation, described above. Facilities are expected to submit 
errors and potential errors according to regulation under the threat of legal penalty. 
Facilities enroll to use the individual error reporting system at the beginnin  of the 
reporting year. The number SNFs reporting errors as reported by the Cecil G.Sheps 
Center for Health Services Research at the University of North Carolina at Chapel Hill 
(Sheps Center) has remained constant for reporting years three, four and five (393 
SNFs)8, 9, 111. A review of the OSCAR data to verify participation rates indicated no 
evidence of change in the number of facilities during the reporting year. Review of 
consistency of facility participation indicates that each facility in our dataset participated 
for the entire reporting year.  
A comparison of the ownership status of the SNFs in the dataset to the SNFs in 
North Carolina is shown in Table 1. Of the number of SNFs licensed in North Carolina 
(423), 32% reported a medication error during the first seven days of a resident's 
admission into the facility. For-profit SNFs in the study (71.5%) were underrepr sented 
when compared to the for-profit SNFs licensed in North Carolina. Yet, for-profit chain 
affiliated SNFs were overrepresented (79.6%), and not-for-profit chain affil ated SNFs 
(38.5%) were underrepresented when compared to facilities licensed in North Carolina.  
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The data set contains structure variables of ownership (profit, not-for-profit), size 
(number of beds), location (urban, rural) and whether the facility is part of a chain of 
nursing homes. The data set does not contain information on government owned 
facilities. Process variables include: type of error, phase in medication process, personnel 
involved in error, effect of the error on resident, and causes of errors. The outcome 
variables are the number of medication errors reported and the adverse impact/effect on 
the resident. The following resident characteristics were used as potential covariates; age, 
gender, cognitive ability, and number of medications taken per day. Analysis of 
Hypothesis 1a was at the facility level using the number of reported medication errors for 
all facilities reporting at least one error, while analysis for Hypothesis 1b, Hypothesis 2, 
and Hypothesis 3 was the reported medication error. In 2007 there were 13,551 errors 
reported, of which 1,234 had a serious impact (harmful). 581 of the errors occurred 
during transition into the SNF, of which 73 were serious9.  
yes % no % n %
NC 2007
Non-Profit 43 46.2% 50 53.8% 93 22.0%
For Profit 246 77.1% 73 22.9% 319 75.4%
Government owned 4 36.4% 7 63.6% 11 2.6%
Total 293 130 423 100.0%
MEQI-IE Study
Not For Profit 15 38.5% 24 61.5% 39 28.5%
For Profit 78 79.6% 20 20.4% 98 71.5%
Total 93  44 137 100.0%
Chain Affiliated Total
Table 1. Comparison of North Carolina Nursing Home Ownership and 
MEQI-IE Ownership
Notes: Source Nursing Home Compare-About Nursing Homes: Center 
for Medicare and Medicaid Services;  FY2007
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Errors were determined to be serious using the National Coordinating Council for 
Medication Reporting and Prevention Index for Categorizing medication errors(NCC 
MERP)6 as modified by Sheps Center researchers in the MEQI report (see Appendix B: 
Figure 2). MEQI reports serious errors (harm) from Categories D-I, and non-serious 
errors (no-harm) from Categories A-C, whereas NCC MERP reports Category D as error, 
no harm9. 
 Types of errors include: wrong resident, product, strength, form, route, time, 
technique, rate of administration, duration and documentation, expired product, dose 
omission, overdose, under dose, expired order, monitoring error, lab work error, and 
other. Types of errors were collapsed into five error categories due to small nu bers of 
errors for each type of error, where each category contains both errors that cause harm 
and errors that do not cause harm. The category of wrong drug is comprised of wrong 
product, wrong product strength, wrong form of product and expired product. Wrong 
dosage errors were collapsed by combining over dose and under dose into wrong dose 
and leaving dose omission. Much of the literature presents dose errors in this manner, 
where dose omission is often the most frequent type of error reported9, 31. Wrong dose 
represents the process of administering the correct medication to the correct resident at 
the correct time but in the wrong dose. Wrong administration is comprised of wrong 
route, wrong time, wrong technique, wrong rate of administration, wrong duration, and 
expired order. Wrong follow up is made up of monitoring errors, labwork errors and 
wrong documentation. The collapsing methodology used follows the groupings noted on 
the individual error incident reporting form facilities used to report medication errors and 
potential medication errors.  
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 Phases in the medication use process include: prescribing, dispensing, 
documenting, administering, and monitoring. Primary personnel involved in the error 
include: licensed practical nurse (LPN), registered nurse (RN), medication aide, 
physician, pharmacist, physician assistant, nurse practitioner, support personnel, resid nt 
or caregiver, student or trainee.  
 The health effects from errors in the data set include: falls, edema, excessive side 
effects, allergic reaction, constipation/diarrhea, cognitive change, change in blood sugar, 
somnolence, cardiac arrest, change in blood pressure, no injury or effect, and other.  
 Possible causes of errors were also collapsed into six categories of causes to 
increase the number in each category. The category of product issues includes medication 
name confusion, product label, and  package design; record issues includes illegible 
handwriting, use of abbreviations, inadequate information, and transcription error; 
dispensing includes medication unavailable, pharmacy closed, pharmacy delivered to 
wrong facility, pharmacy delivered wrong medication, and other dispensing issues; 
facility issues include poor work conditions, shift change, following faulty policies, and 
frequent distractions on the floor; personnel issues include poor communication, basic 
human error, emergency on floor, exhaustion, too much workload, and improper training, 
and other causes remains in a category by itself. The grouping methodology used to 
create causes of error categories also follows the groupings noted on the individual error 
incident reporting form. The individual error incident reporting form allows for multiple 
selections for reporting the possible causes or reasons for the error or potential error, 
therefore the categories are not mutually exclusive and are not the sum of the individual 
cause variables.  
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3.3 Ethical Considerations 
 This study of an observational case series of medication errors and potential errors 
for residents at admission into North Carolina nursing homes followed the ethical, 
research, and operational guidelines of the researching institution including: Institutional 
Review Board approval (UNCC, Office of Research Protocol number 08-07-29), 
Institutional Review Board Training Tutorial, and those of the Data Use Agreement 
signed with the Sheps Center. The Sheps Center under contractual agreement with the 
State of North Carolina collects and maintains the MEQI data. Informed consent was not 
obtained as the data was de-identified through a nursing home identification encryptio  
when received by the investigator from the Sheps Center. Efforts were made to ensure 
confidentiality of the study data including being stored on a computer with password 
protection and accessed only by the researcher. The data will be destroyed at the end of 
the study as prescribed in the data use agreement.  
3.4 Data analysis  
Analysis was conducted using SAS 9.1 (Cary, NC). Sample size and power 
analysis were conducted using Schesselman and associate's sample size equat on for two 
proportions and found to be appropriate112.  
 
MEQI reported 9% of the errors as serious or caused harm over the four year 
reporting period, using this as proportion one (p1) and twice (18%) that as proportion two 
(p2), a sample size of 450 was calculated with α as the type I error rate 0.05, and β the 
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type II error rate 0.20. The data set contains 581 errors reported during the seven days 
following admission. 
 With a small data set, such as this, missing data could bias the findings. Therefore 
the data was evaluated for missing variables. The Rural-Urban Commuting Area cod  
(RUCA), a classification system used to aggregate geographic locations by population 
demographics, for one observation was zero (0); we believe this should have been coded 
as a ten (10); this is a 90 bed not-for-profit facility noted as not affiliated with a chain. 
Missing values for age, gender and cognitive ability were identified for seven 
observations that were reported as NA. The observations with these data missing did not 
appear to be systematically different from the observations without missing data. 
Therefore the values were assessed to be missing completely at random nd dropped, 
resulting in 574 observations used in bivariate analysis and logistic regression analysis.  
Number of medications the resident was taking at the time of the medication error 
was missing for 332 of the 581 reported medication errors. Therefore a sub-analysis of 
the data was completed and assessed using 249 reported medication errors to determine if 
the difference was statistically significant113. The number of medications appears to 
impact the models used to test Hypothesis 2: (Medication errors are more likely to b  
harmful when administering is reported as the medication use phase compared to any 
other phase in the medication use process during the seven days following admission) 
and Hypothesis 3: (Medication errors are more likely to be harmful when wrong dose is 
reported as the error type compared to any other type of error during the seven days 
following admission). This is likely to be due to the model being under-powered, with 
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only 249 observations, 12 variables and 236 degrees of freedom. Therefore, two models 
were used in the analysis; one with number of medications in the model and one without.  
Variables were assessed for multicollinearity using multicollinear ty diagnostic 
statistics produced by linear regression analysis. Variance inflation factor or each 
independent variable was examined and found to be less than 2.5. In a logistic regression 
model values above 2.5 are thought to cause concern for multicollinearity114.  
Descriptive statistics, including chi square analysis, were obtained for the 
structure, process and outcome variables of interest. Structure variables of profit status 
(for-profit, not-for-profit) and chain affiliation (chain, free-standing) are dichotomous, 
RUCA is a nominal polychotomous variable, frequencies for each category were 
obtained. The data set does not differentiate between the multiple types of for-profit 
ownership types (i.e. corporation, partnership, or limited liability corporation), or ot-for-
profit ownership types (i.e. church, community). RUCA codes were aggregated into four 
categories (Categorization A)115, and renamed location. The new variable, location, 
contains the following categories; urban focused, large rural/town, small rural town, and 
isolated small rural town. For the multivariate analysis location was dichotomized as 
urban versus all other. Bed size (number of licensed beds in the SNF) is an interval 
variable that was categorized as follows: > 50, 51-100, 101-150, and >151 beds. For the 
multivariate analysis bed size was categorized < 100 (reference group), 101-150, and 
>151 beds.  
Chi square analysis was conducted for each of the tables to assess homogeneity 
and measures of association between the variables present. For some independent 
variables chi square analysis was assessed for each category of the variabl  or for the 
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collapsed variable that includes several categories. For other variables such as (primary 
error type) assessment of homogeneity and measures of association were conducted both 
at the category level and the variable level. Details for chi square analysis re indicated in 
the footnote of each table. 
Process variables include: type of error, phase in medication use process, 
personnel involved in error, effect of error on resident, and causes of errors. Type of 
error, effect of error on resident, and cause of error are presented as separ te dichotomous 
variables, 0 if not indicated and 1 if indicated. Medication phase and personnel involved 
are nominal polychotomous variables. Frequencies of occurrence for each variable were 
obtained. 
The facility-level outcome variable for Hypothesis 1a, number of medication 
errors, is an interval (count) variable. The outcome variable for Hypotheses 1b, 2, and 3 
is a dichotomous variable indicating whether the resident was harmed by the medication 
error (1) or not (0). This variable is constructed using a nominal polychotomous variable 
from the data with 9 possible categories of which only 1-6 have occurrences in the data 
set. Categories of capacity to cause harm, did not reach resident, and did not cause harm 
were recoded to 0, indicating no harm. Categories of required monitoring/interve tion, 
temporary harm to resident, and temporary harm to resident with trip to emergency oom 
were recoded to 1, indicating that the resident endured harm. This follows the 
categorization utilized in MEQI report9, in which categories 1-3 indicate minor errors and 
categories 4-9 indicate serious errors.  
Age, gender, cognition, and number of medications taken by the resident were 
assessed for confounding and interaction in each error level model (Hypothesis 1b, 
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Hypothesis 2 and Hypothesis 3). Previous research on age, gender and cognition as 
potential confounders indicate conflicting results in their association with harm from the 
medication error. Therefore they were tested by comparing the estimated coefficient for 
the risk factors in the harm models with and without the covariates (age, gender, 
cognition and number of medications) in the model. The estimated coefficients for the 
risk factors did not change when age, gender or cognitive ability were removed fr m the 
model. The final logistic regression model includes age, gender and cognition to control
for these characteristics.  
 Variables with known clinical significance (through a priori studies) and 
statistical significance through bivariate analysis were included in the regr ssion models, 
taking into account power analysis. For example, prior research indicates age and number 
of medications as risk factors, therefore were included in the analysis of harm models 
(Hypothesis 1b, Hypothesis 2, & Hypothesis 3). Analysis of Hypothesis 1a was at the 
facility level and did not include resident characteristics. Since the error r ports do not 
represent a random sample of residents from the facility there is no reason to believe that 
resident characteristics as constructed from the medication error data are representative of 
the facility population. Including resident characteristics in the analysis could bias the 
results with no ability to determine the direction of the bias. Average resident ag  for 
each facility will represent only ages of residents for a reported medication error not the 
average age of the residents in the facility. Therefore when evaluating facility 
characteristics average resident age obtained from the data could be considerably higher 
or lower than the average resident age for the facility and not be representative of the 
facility acuity level. The data use agreement prohibited matching of the error data to 
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external data sources that would contain facility level measures. Therefore r sid nt 
characteristics were not included in facility level analysis.  
 Independent variables in each of the models were assessed for confounding and 
interactions. An interaction was identified with ownership status and chain membership, 
therefore a second model was used and analysis and interpretation were based on the 
significance of the interaction effect. Interactions were tested by creating strata of 
independent variables of interest (e.g. profit status and chain status) then using regression 
evaluated the increase in risk of medication error occurring by strata. The interaction term 
for chain membership and profit status was included in the final models for both negative 
binomial and logistic regression analysis. 
 Multivariable analysis was used to evaluate the relationships of specific SPO 
elements contributing to harmful medication errors. Negative binomial regression was 
used to test Hypothesis 1a: For-profit nursing homes will report a higher rate of 
medication errors during the seven days following admission than not-for-profit nurs ng 
homes. Negative binomial regression is a generalization of the Poisson model that allows 
for over dispersion (variance exceeds the mean) in count data, making it more useful with 
real-life data which are often characterized by over dispersion. Data ch r cterized by 
over-dispersion can yield underestimates of standard errors which then lead to incorrect 
interpretation of statistical significance. Use of negative binomial regression corrects for 
the standard errors. Logistic regression was used to test the other three hypotheses 
(Hypothesis 1b, Hypothesis 2, & Hypothesis 3). 
Negative binomial regression, used to determine the relationship between nursing 
home ownership and the number of medication errors that occurred during the seven days 
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following admission, is discussed below. It is important to note that the number of 
medication errors must be greater than zero for a facility to be included in the aalysis. 
As such, the sample being considered is more error prone or reports more errors than the 
general population of nursing homes if some nursing homes report no errors. For a 
discrete random variable, Y (number of medication errors), with observed frequencies, yi, 
for i=1,…,N, where yi is non-negative, and xi includes the regressors, the negative 
binomial regression model is as follows:    
exp( )Prob(Y=y | ) e / !i iyi i iy
λ εε λ−= ,  
Where ln i ixλ β ε′= +  and ε  has a gamma distribution with a mean of one and a 
variance of α . The dependent variable Y, is the count of the number of medication errors 
reported by the nursing facility i, i=1,2,3,…, n, where n denotes the sample size. The 
distribution of the count data (medication errors) is dependent upon exogenous variables 
some observed (xi) and others unobserved. Let (ε ) represent the unobserved variables 
and measurement errors on the data. The estimated coefficients (β̂ ) may be interpreted 
as the log of the incidence rate ratio116, 117.  
The link between the expectation of the dependent variable (medication error) and 
the linear predictor (ownership type) is a logarithmic function. The rate at which 
medication errors occur is the incidence rate. Chain affiliation, bed size and facility 
location are included in the model as control variables. For ease of interpretation, we 
reported the incidence rate ratio estimates for each explanatory variable. The expression 
(100*(exp[β̂ ]-1) depicts the percentage change in the incidence or rate of medication 
error for each strata of the explanatory variable in the model.  
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 Hypotheses 1b, 2, and 3 were tested using logistic regression, as the dependent 
variable in all three cases is whether a medication error was harmful or not.The structure 
variables include the interaction terms not-for-profit and part of a chain, for-profit and 
part of a chain, for-profit not part of a chain, with not-for-profit not part of a chain as the 
reference group. Also included are categorical variables location and bed size. Process 
variables include the phase in the medication use process where the error occu red 
(prescribing, dispensing, documenting, administering, and monitoring), type of 
medication error by category, primary personnel involved in error dichotomized to LPN 
versus all other personnel, and cause of error.  
Two sets of models were developed for the analysis of Hypothesis 1b, Hypothesis 
2, and Hypothesis 3. As noted above, there were 332 missing observations for the 
variable number of medications, reducing the observations used for analysis to 259 when 
number of medications is included in the model. Analysis of Hypothesis 1b, Hypothesis 
2, and Hypothesis 3 without number of medications is shown as Model 1 and with 
number of medications Model 2. Resident characteristics in Model 1 include age, gender, 
and cognitive ability; Model 2 adds number of medications. Bivariate analysis of process 
variables did not indicate statistical significance for all variables. Previous studies 
indicate conflicting results for age, gender and cognitive ability as risk factors for 
medication errors; therefore even though bivariate analysis did not indicate statistical 
significance they were included in the expanded model. To evaluate the significance of 
structure and process variables other than the predictor variables on the impact of a 
reported medication error, reduced models were analyzed. The reduced models (Model 1 
and Model 2) included the interaction variables for ownership and chain status, types of 
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medication errors and phases of the medication use process. The expanded models 
(Model 1 and Model 2) included the reduced model variables plus structure variables 
location and bed size; process variables personnel and reported causes of medication 
error; and resident characteristics age, gender, and cognitive ability.  
The general version of both the reduced and expanded models for testing 
Hypotheses 1b, 2 and 3 is Pr  1|1, 2, … ,  

 
.  
For the reduced models, the set of explanatory variables used is a subset of the set of 
variables used in the expanded models. Odds ratios and 95% confidence intervals for 
covariates were obtained for all models.  
  Goodness of fit logistic regression diagnostics were used to examine the 
conceptual model. These tests were used to indicate satisfactory models for use in 
discriminating between factors contributing to harm occurring to the resident duri g 
admission into the nursing home. The Akaike Information Criterion (AIC) were 
evaluated for each of the four logistic regression models. These criteria prsent the 
association of predicted probability of the variables in the model while adjusting for the 
number of variables and number of observations used in the model; lower values indicate 
a better fitting model. Lower AIC values were obtained for both the reduced and 
expanded models with number of medications included in the model. The other test of 
model fit assessed is the area under the ROC (receiver operator curve) represented by the 
c-value obtained in the association of predicted probabilities and observed responses 
output section of the fit test analysis. The c-value ranged from 0.71 – 0.81 for the four 
models. Models with the number of medications included had higher values. The model 
fit tests support the models’ ability to discriminate between the likelihood of profit status, 
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administration phase of the medication use process, or wrong dose as contributing to 
harm occurring when a medication error occurs during admission to the nursing home.   
 
 
CHAPTER 4: RESULTS 
 
 
 The purpose of the study is to elucidate the relationships and inter-relatedness of 
specific SPO elements contributing to harmful medication errors for the vulnerab e 
people who reside in SNFs. In this chapter the findings of the study are presented.  
 As noted above, the dataset contains 13,551 medication errors that were reported 
by 203 North Carolina SNFs from October 1, 2006 - September 30, 2007 using the 
MEQI-Individual Error (MEQI-IE) reporting method, 581 of those occurred in 138 (68%) 
SNFs during the first seven days of admission into the nursing home and were used for 
this analysis. 
4.1 Analysis by Profit Status 
 4.1.1  Facility and Resident Characteristics 
  As shown in Table 2, 137 SNFs reported the 581 medication errors that occurred 
during the first seven days of admission into the nursing home (One facility was droppe  
due to incorrect location code). The average facility size was 120 (SD 40.9) beds, 62% of 
the facilities had 101 beds or more, 67% were part of a chain, and 88% were either urban 
focused or in a large town.  
 As shown in Table 3, residents experiencing medication errors were 
predominately female (65%), unable to direct their own care (58.5%), and 75 years of age 
or older (69.3%). Harm occurred in 73 (12.6%) of the reported errors. The average 
number of medications taken was 12.0 (SD 4.9). While only 259 of the reported 
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medication errors indicated the number of medications being taken at the time of the 
incident, 103 of the reports indicated residents received between 7-12 medications.  
  4.1.1.1 Bivariate analysis of profit status and facility characteristics 
 For-profit SNFs reported an average of 4.13 medication errors per facility nd a 
rate of 3.4 per 100 beds, whereas not-for-profit facilities reported an average of 4.4 
medication errors and a rate of 3.8 per 100 beds. For-profit facilities had on average 121 
beds, with approximately one half (58.2%) located in urban focused locations. Not-for-
profit SNFs are primarily in urban focused locations (71.8%), and had on average had 
118 beds. A large number (80%) of for-profit SNFs are members of a chain; only 38% of 
the not-for-profit SNFs are affiliated with a chain. In summary, there are twice as many 
for-profit SNFs they tend to be larger, and affiliated with chains, whereas not-for-profit 
SNFs reported more errors on average and had more facilities in urban focused area.  
36 
 
 
 
 
 
  4.1.1.2 Bivariate analysis of profit status and resident characteristics 
 Residents 85 or older experienced fewer (175) medication errors than those aged 
75-84 years of age (228). For-profit facilities reported 63.5% of the resident  who 
experienced a medication error could not direct their own care, two thirds were women, 
and 68.8% were over the age of 75, whereas 47.2% of the not-for-profit facilities' 
residents could not direct their own care and 73.4% were over the age of 75. Residents 
experiencing a medication error in for-profit facilities on average wer prescribed 12.2 
(SD 4.9) medications per day whereas those in not-for-profit facilities were pr scribed on 
average 11.8 (SD 5.1). For-profit SNFs reported 11.9% of the medication errors caused 
harm whereas not-for-profit SNFs reported 14.2% of the errors caused harm. In 
N % N % N % N % N %
Total 39 28.5% 98 71.5% 44 32.1% 93 67.9% 137 100
Facility part of a Chain ****     
no 24 61.5% 20 20.4%    44 32%
yes 15 38.5% 78 79.6% 93 67%
µ (sd) * 118  (42.8) 121  (40.5) 121 (40.4)
<50 3 7.7% 2 2.0% 2 4.4% 3 3.2% 5 4%
51-100 12 30.8% 34 34.7% 14 31.1% 32 34.4% 47 34%
101-150 18 46.2% 42 42.9% 21 46.7% 39 41.9% 60 43%
>151 6 50.0% 20 20.4% 7 15.6% 19 20.4% 26 19%
Urban focused 28 71.8% 57 58.2% 27 60.0% 58 62.4% 85 62%
Large rural/town 8 20.5% 28 28.6% 14 31.1% 22 23.7% 36 26%
Small rural town 1 2.6% 8 8.2% 2 4.4% 7 7.5% 9 7%
Isolated small rural town 2 5.1% 5 5.1% 1 2.2% 6 6.5% 7 5%
Notes: RUCA code for one observation coded (0), dropping one facility from analysis from 
138 to 137. Chi square tests of independence were condu ted for facility characteristics. 
Statistically signficant differences in profit status for each characteristic are indicated using 
*<.05; **<.01; ***<.001.
Table 2. Descriptive statistics for facility characteristics by facility profit status and chain 
affiliation
Not-for Profit For Profit Total
Not Chain 
Affilated 
Chain 
Affiliated
Facility location by RUCA code 
Facility size  by number of beds 
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summarizing the errors, for-profit facilities have younger patients, but they are more 
likely to take more medications and are less likely to be able to direct their own care on 
average.  
 
 
 
N % N % N %
Total 173 100 401 100 574 100
Resident Age      
µ (sd) 78.5 (12.0) 77.4 (11.5)
<64 20 11.6% 52 13.0% 72 12.5%
65-74 26 15.0% 73 18.2% 99 17.2%
75-84 70 40.5% 158 39.4% 228 39.7%
>85 57 32.9% 118 29.4% 175 30.5%
Resident Gender      
Male 57 32.4% 140 34.6% 197 33.9%
Female 116 65.9% 261 64.4% 377 64.9%
Patient able to direct own 
care ***
Yes 68 38.6% 133 32.8% 201 34.6%
No 83 47.2% 257 63.5% 340 58.5%
Unknown 22 12.5% 11 2.7% 33 5.7%
Number of Medications 
(332 missing) N=69  N=180  N=249  
µ (sd) 11.8 (5.10) 12.2 (4.9)
1-7 meds 15 21.7% 30 16.7% 45 18.1%
7-12 meds 26 37.7% 77 42.8% 103 41.4%
13-18 meds 19 27.5% 45 25.0% 64 25.7%
18-30 meds 9 13.0% 28 15.6% 37 14.9%
Impact
N=581 no missing observations
No Harm 151 85.8% 357 88.1% 508 87.4%
Harm 25 14.2% 48 11.9% 73 12.6%
Notes: Chi square tests of independence were conducted for resident 
characteristics. Statistically signficant differencs in profit status for each 
characteristic are indicated using *<.05; **<.01; ***<.001. 
Resident age, gender and ability to direct own careare missing 7 observations 
reducing the number used for analysis to 574.
Table 3. Descriptive statistics for resident characterisitics of medication errors by 
facility profit status
Not-for Profit For Profit Total
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4.1.2 Medication Error Characteristics 
 Frequencies for probable and potential causes of errors, primary type of error, and 
personnel involved in medication errors by ownership type are presented in Table 4. 
Basic human error was reported as the primary cause of error for 58.2%, transcription 
error for 35.6%, and poor communication for 7.1% of the medication errors. Causes of 
error by category indicate that personnel issues accounted for 65.4% medication errors, 
and record issues were reported for 39.2%. Over one third of the primary errors were 
dose omissions (36.3%). Errors occurred most frequently in the documenting (46.6%) 
and administering (33.4%) phases of the medication use process. The primary personnel 
involved in the errors were LPNs (64.2%) and RNs (26.5%); this follows the staffing 
patterns used by SNFs where LPNs often outnumber RNs two to one. Overall, reported 
medication errors were primarily dose omissions identified by LPNs with basic human 
error as the primary error cause and the documenting phase as the most prevalent phase 
of the medication use process. 
  4.1.2.1 Bivariate analysis of profit status and medication error type 
 For-profit SNFs reported 63.5% of the errors were due to basic human error, 
37.5% transcription error, and 8.1% due to poor communication. Not-for-profit SNFs 
reported 46% were due to basic human error, 31.3% transcription error and 4.5% to poor 
communication. For-profit SNFs reported 36.8% of the primary error types were dose 
omissions, 15.1% were overdoses, whereas not-for-profit SNFs reported 35.2% were 
dose omissions, with only 9.7% overdoses. Wrong dose (combination of overdose and 
under-dose) occurred in 22.5% of the for-profit SNF errors and 14.8% of the not-for-
profit errors. Wrong drug was reported for 19.9% and wrong patient 8.0% of the errors 
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reported by not-for-profit facilities, while for-profit SNFs reported wrong drug and wrong 
patient errors for 10.6% and 1.7%, respectively. For-profit SNFs reported 10.1% of the 
errors were wrong administration, twice the frequency of not-for-profit SNFs. To 
summarize, 70% of the medication errors reported by for-profit SNFs were attributable to 
personnel issues with over one-third of the errors being dose omission errors, and for-
profit SNFs had a higher proportion of wrong drug and wrong patient errors.  
 Medication errors occurred most often during the documenting phase of the 
medication use process. For-profit SNFs reported 49.1% of the medication errors 
occurred during documentation, whereas not-for-profits reported 40.9% occurred during 
documentation of the medication. In contrast, for-profit facilities reported fewer (32.3%) 
medication errors during the administering phase than not-for-profit facilities (35.8%).  
 For-profit facilities reported licensed practical nurses (LPN) as the primary 
personnel involved in 69.4% of the medication errors and registered nurses (RN) in 
24.0%, whereas not-for-profit facilities reported LPNs were the primary personnel 
involved in 52.3% and RNs for 31.8% of the medication errors. Medication aides were 
reported as the primary personnel in 4 and pharmacists in 10 (2.5%) of the errors reported 
by for-profit facilities, whereas not-for profits reported no errors by medication aides and 
13 (7.4%) errors by pharmacists.  
For-profit SNFs had more beds and tended to be affiliated with a chain, residents 
were on average younger and were ordered more medications, but fewer could direct 
their own care than not-for-profit SNFs. For-profit SNFs reported fewer erro s that 
caused harm. In both types of facilities more errors occurred during the documentation 
phase and more were dose omission errors.   
40 
 
 
 
 
N % N % N %
Total 176 100 405 100 581 100
Causes for reported errors      
Product Issues 9 5.1% 20 4.9% 29 5.0%
Medication name confusion 3 1.7% 13 3.2% 16 2.8%
Medication incorrectly labeled 5 2.8% 5 1.2% 10 1.7%
Package design 2 1.1% 2 0.5% 4 0.7%
Record Issues 61 34.7% 167 41.2% 228 39.2%
Illegible handwriting 0 0.0% 8 2.0% 8 1.4%
Prescription order unclear 5 2.8% 12 3.0% 17 2.9%
Use of abbreviations 1 0.6% 1 0.2% 2 0.3%
Transcription error * 55 31.3% 152 37.5% 207 35.6%
Dispensing 24 13.6% 37 9.1% 61 10.5%
Medication unavailable 3 1.7% 15 3.7% 18 3.1%
Pharmacy closed 0 0.0% 2 0.5% 2 0.3%
Pharmacy delivered wrong 
medication * 10 5.7% 0 0.0% 19 3.3%
Other dispensing issues * 13 7.4% 16 4.0% 29 5.0%
Facility Issues 27 15.3% 47 11.6% 74 12.7%
Poor working conditions 0 0.0% 1 0.2% 1 0.2%
Shift change 4 2.3% 6 1.5% 10 1.7%
Following faulty policies/systems * 13 7.4% 12 3.0% 25 4.3%
Distractions on floor 10 5.7% 31 7.7% 41 7.1%
Personnel Issues * 98 55.7% 282 69.6% 380 65.4%
Poor communication * 8 4.5% 33 8.1% 41 7.1%
Basic human error *** 81 46.0% 257 63.5% 338 58.2%
Emergency on floor 0 0.0% 1 0.2% 1 0.2%
Exhaustion 0 0.0% 1 0.2% 1 0.2%
Work overload 1 0.6% 4 1.0% 5 0.9%
Improper training *** 15 8.5% 1 0.2% 16 2.8%
Other causes * 17 9.7% 17 4.2% 34 5.9%
Total Causes for reported error 236 570 806
Primary Error Type ***     
Wrong Patient *** 14 8.0% 7 1.7% 21 3.6%
Wrong Drug *** 35 19.9% 43 10.6% 78 13.4%
Wrong product 13 7.4% 24 5.9% 37 6.4%
Wrong strength 19 10.8% 15 3.7% 34 5.9%
Wrong form 3 1.7% 4 1.0% 7 1.2%
Dose Omission 62 35.2% 149 36.8% 211 36.3%
Table 4. Descriptive statistics of error characterisi cs by facility profit status
Not-for Profit For Profit Total
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Table 4 (continued) 
 
 
 
 
Wrong Dose * 26 14.8% 91 22.5% 117 20.1%
Overdose 17 9.7% 61 15.1% 78 13.4%
Underdose 9 5.1% 30 7.4% 39 6.7%
Wrong Administration * 10 5.7% 41 10.1% 51 8.8%
Wrong time 4 2.3% 11 2.7% 15 2.6%
Wrong technique 1 0.6% 2 0.5% 3 0.5%
Wrong rate of administration 0 0.0% 2 0.5% 2 0.3%
Wrong duration 0 0.0% 5 1.2% 5 0.9%
Expired order 5 2.8% 21 5.2% 26 4.5%
Wrong Followup 12 6.8% 40 9.9% 52 9.0%
Monitoring error 3 1.7% 3 0.7% 6 1.0%
Labwork error 1 0.6% 6 1.5% 7 1.2%
Wrong documentation 8 4.5% 31 7.7% 39 6.7%
Other 17 9.7% 34 8.4% 51 8.8%
Total Primary Error Type 176 100.0% 405 100.0% 581 100.0%
Medication Use Process    
 Prescribing 13 7.4% 15 3.7% 28 4.8%
Dispensing 25 14.2% 53 13.1% 78 13.4%
Docmumenting 72 40.9% 199 49.1% 271 46.6%
Administering 63 35.8% 131 32.3% 194 33.4%
Monitoring 3 1.7% 7 1.7% 10 1.7%
Total Medication Use Process 176 100.0% 405 100.0% 581 100.0%
Primary personnel involved in 
error      
LPN 92 52.3% 281 69.4% 373 64.2%
RN 56 31.8% 98 24.2% 154 26.5%
Medication Aide 0 0.0% 4 1.0% 4 0.7%
Physician 6 3.4% 7 1.7% 13 2.2%
Pharmacist 13 7.4% 10 2.5% 23 4.0%
Nurse Practitioner 0 0.0% 1 0.2% 1 0.2%
Support Personnel 9 5.1% 4 1.0% 13 2.2%
Total Primary Personnel 176 100.0% 405 100.0% 581 100.0%
Bold indicates categories. Causes of errors is not mutually exclusive as selection of multiple 
causes was allowed.
Notes: Chi square tests of independence were conducted for each of the error characteristics 
indicated in bold in the left-hand column. In addition chi square tests of independence for 
each of subcategories of cause and primary error type were conducted. Statistically significant 
differences in profit status for each characteristic are indicated using*<.05; **<.01; 
***<.001.  
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4.1.3 Multivariate analysis by ownership status   
 The findings from the negative binomial regression models are presented in Table 
5. Model 1 indicates no difference in the incidence rate ratio for medication errors
between for-profit SNFs and not-for-profit SNFs (IRR,1.16; 95% CI 0.79-1.69). Nursing 
homes that were members of a chain reported 42% (IRR, 0.58; 95% CI 0.41-0.83) fewer 
medication errors than those not affiliated with a chain. Model 2 suggests that being a 
member of a chain may interact with ownership status. According to Model 2, a not-for-
profit SNF that is a member of a chain is expected to have a 51% (IRR, 0.49; 95% CI .25-
.92) lower rate of medication errors than a for-profit SNF that is not part of a chain 
holding all other variables in the model constant. A for-profit SNF that is a member of a 
chain is expected to have a 27% (IRR, 0.63; 95% CI 0.40-0.99) lower rate of medication 
errors than a for-profit SNF that is not a member of a chain holding all other variables in 
the model constant. Both models indicate a SNF with greater than 151 beds is expected to 
have two times the rate (IRR, 2.02; 95% CI 1.33-3.08) of medication errors than a SNF 
100 beds or less holding all other variables in the model constant (Table 5). 
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4.2 Analysis by harm endured by resident 
 4.2.1 Bivariate analysis 
  4.2.1.1. Bivariate analysis of harm and primary type of error  
 Examination of the primary error types and categories of errors by whether the 
medication error caused harm is shown in Table 6. Harm occurred in 12.6% of the 
reported errors, where 32.9% were reported as wrong dose, 30.1% dose omission, and 
12.3% as wrong drug. Of the errors where no harm was reported, 37.2% were dose 
Table 5. Medication Error Incidence Rate Ratios by Facility Status
Variable/Category IRR 95% CI IRR 95% CI
Ownership
Not For Profit 
  For Profit 1.16 .79 - 1.70
Affiliated with a chain
No
Yes 0.58 .41 - .83
Interaction
For-profit & not Chain member 
Not-for-profit & Chain member 0.49 .26 - .92
For-profit & Chain member 0.63 .40 - .99
Not-for-profit & not Chain member 0.96 .56 - 1.65
Location 
Non-urban
Urban 0.88 .65 - 1.20 0.86 .63 - 1.19
Bed Size
< 100
101-150 1.49 1.04 - 2.14 1.49 1.04 - 2.13
> 151 2.05 1.35 - 3.11 2.02 1.33 - 3.08
Model  1 Model  2
Note: Model 1 no interaction between ownership and profit status, Model 2 shows 
interaction between ownership profit status.
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omissions, 18.3% wrong dose and 13.6% wrong drug. Statistical significance between 
harm and no harm was found only in wrong dose errors. 
 
 
   
N % N % N %
Total 508 100.0% 73 100.0% 581 100.0%
Wrong Patient 17 3.3% 4 5.5% 21 3.6%
Wrong Drug 69 13.6% 9 12.3% 78 13.4%
Wrong product 32 6.3% 5 6.8% 37 6.4%
Wrong strength 30 5.9% 4 5.5% 34 5.9%
Wrong form 7 1.4% 0 0.0% 7 1.2%
Dose Omission 189 37.2% 22 30.1% 211 36.3%
Wrong Dose  * 93 18.3% 24 32.9% 117 20.1%
Overdose 59 11.6% 19 26.0% 78 13.4%
Underdose 34 6.7% 5 6.8% 39 6.7%
Wrong Administration 48 9.4% 3 4.1% 51 8.8%
Wrong time 15 3.0% 0 0.0% 15 2.6%
Wrong technique 2 0.4% 1 1.4% 3 0.5%
Wrong rate of 
administration
2 0.4% 0 0.0% 2 0.3%
Wrong duration 5 1.0% 0 0.0% 5 0.9%
Expired order 24 4.7% 2 2.7% 26 4.5%
Wrong Follow-up 47 9.3% 5 6.8% 52 9.0%
Monitoring error 4 0.8% 2 2.7% 6 1.0%
Labwork error 6 1.2% 1 1.4% 7 1.2%
Wrong documentation 37 7.3% 2 2.7% 39 6.7%
Other 45 8.9% 6 8.2% 51 8.8%
Category Totals 508 87.4% 73 12.6% 581 100.0%
Table 6. Examination of primary errors and error categories by harm
No Harm Harm Total
Notes: Chi square tests for independence were conduted for each of the error 
characteristics indicated in bold in the left-hand column. Statistically signficant 
differences in harm for each characteristic are indicated using *<.05. Bold indicates 
categories. The category total is the sum of the bold categories and percent of the 
total errors (i.e 73/581)
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4.2.1.2. Bivariate analysis of harm and probable and potential causes of errors   
 Descriptive statistics for probable and potential causes of reported errors by 
whether the medication error caused harm are shown in Table 7. The causes of error do 
not sum to the categories of cause due to the opportunity to select more than one cause 
when submitting the incident report. Of the errors that caused harm 56.2% were reportd 
as personnel issues which include basic human error and 38.4% reported as recording 
issues which includes transcription errors. Of the errors where no harm occurred 66.7% 
of the errors were reported as personnel issues and 39.4% were recording issues. Harm 
was reported for 10.4% of the errors caused by basic human error, whereas package
design (25%), illegible handwriting (25%), and distractions on the floor (22%) were 
reported to cause harmful errors more frequently. In summary, personnel issues are often 
reported as the cause of errors but result in harm less frequently than other reportd 
causes such as package design and illegible handwriting.  
 
 
 
 
 
 
 
N  N  N %
Total 508 Column% Row % 73 Column% Row %581 100.0%
Product Issues 24 4.7% 82.8% 5 6.8% 17.2% 29 5.0%
Medication name confusion 14 2.8% 87.5% 2 2.7% 12.5% 16 2.8%
Medication incorrectly labeled 8 1.6% 80.0% 2 2.7% 20.0% 10 1.7%
Package design 3 0.6% 75.0% 1 1.4% 25.0% 4 0.7%
Record Issues 200 39.4% 87.7% 28 38.4% 12.3% 228 39.2%
Illegible handwriting 6 1.2% 75.0% 2 2.7% 25.0% 8 1.4%
Prescription order was unclear 14 2.8% 82.4% 3 4.1% 17.6%17 2.9%
Use of abbreviations 2 0.4% 100.0% 0 0.0% 0.0% 2 0.3%
Transcription error 183 36.0% 88.4% 24 32.9%11.6% 207 35.6%
Table 7. Examination of causes of errors and categories of causes of errors by harm
No Harm Harm Total
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Table 7 (continued) 
 
 
 
  
  4.2.1.3 Bivariate analysis of the medication use process and facility and 
resident characteristics 
 
Reported medication error frequencies by phases of the medication use process 
are shown in Tables 8 and 9 (Appendix C and Appendix D). Documenting and 
administrating were reported as the primary phase of the medication use process for 
46.6% and 33.4% of the reported errors, respectively. For-profit SNFs reported 73.4% of 
the documenting errors, 67.5% of the administering errors, and only 53.5% of the 
prescribing errors. SNFs affiliated with chains reported 60.2% of the documenting rrors 
and 59.3% of the administering errors, while those not affiliated with a chain reported 
Dispensing 54 10.6% 88.5% 7 9.6% 11.5% 61 10.5%
Medication unavailable 15 3.0% 83.3% 3 4.1% 16.7% 18 3.1%
Pharmacy closed 2 0.4% 100.0% 0 0.0% 0.0% 2 0.3%
Pharmacy delivered wrong 19 3.7% 100.0% 0 0.0% 0.0% 19 3.3%
Other dispensing issues 24 4.7% 82.8% 5 6.8% 17.2% 29 5.0%
Facility Issues 61 12.0% 82.4% 13 17.8% 17.6% 74 12.7%
Poor working conditions 1 0.2% 100.0% 0 0.0% 0.0% 1 0.2%
Shift Change 10 2.0% 100.0% 0 0.0% 0.0% 10 1.7%
Following faulty policies 21 4.1% 84.0% 4 5.5% 16.0% 25 4.3%
Distractions on floor 32 6.3% 78.0% 9 12.3% 22.0% 41 7.1%
Personnel Issues 339 66.7% 89.2% 41 56.2% 10.8% 380 65.4%
Poor communications 36 7.1% 87.8% 5 6.8% 12.2% 41 7.1%
Basic human error 303 59.6% 89.6% 35 47.9% 10.4% 338 58.2%
Emergency on floor 1 0.2% 100.0% 0 0.0% 0.0% 1 0.2%
Exhaustion 1 0.2% 100.0% 0 0.0% 0.0% 1 0.2%
Too much workload 5 1.0% 100.0% 0 0.0% 0.0% 5 0.9%
Improper training 13 2.6% 81.3% 3 4.1% 18.8% 16 2.8%
Other causes 28 5.5% 82.4% 6 8.2% 17.6% 34 5.9%
Total Reported Causes 706 100 806
Notes: Individual causes do not equal category sums d e to the ability to select more than 
one cause. Categories of causes of errors shown in bold. Column percent is equal to the n 
for the category divided by n for the column (i.e. 24/508=4.72%). Row percent is equal to 
the n for the category divided by the n for the row(i.e. 24/29=82.76%)  
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75% of the prescribing errors. Prescribing errors were reported more in larger SNFs 
(35.7%, >151 beds) and monitoring errors in smaller SNFs (60%,101-150 beds). Error 
frequencies for the medication use process by impact show that harm occurred in 46.4% 
of the prescribing errors, 35.6% of the documenting errors, and 11.3% of the 
administering errors. The average age of the residents experiencing a medication error 
during the administering phase is 76.8 (SD 11.7), whereas the average age for the 
residents experiencing a medication error during the prescribing or monitoring phases is 
72.3 (SD 12.4) and 85.8 (SD 11) respectively. In summary, prescribing errors caused 
harm more often than errors in any other phase of the medication use process, but errors 
occur more often in the documenting phase.  
  4.2.1.4 Bivariate analysis of the medication use process and error 
characteristics 
  
Descriptive statistics of the error characteristics by the medication use process are 
presented in Table 9. Personnel issues were reported as the primary cause of the err r for 
59.6% of the documenting errors, 77.8% of the administering errors, and 67.9% of the 
prescribing errors. One half of the dose omission errors occurred in the documenting 
phase; while only 36% occurred during administering. Wrong dose was reported for only 
18.6% of the administering errors, yet 23.1% of the dispensing errors were wrong doses. 
Physicians were reported as the primary personnel involved in prescribing errors fo  nly 
39.3% of the errors, with LPNs for 32.1% and RNs for 25%. Pharmacists were reported 
as the primary personnel for only 29.5% of the dispensing errors, LPNs were responsible 
for 56.4%, RNs 11.5% and medication aides 2.6%. Of the four errors reported to be made 
by medication aides one was during the administering phase, one during documenting, 
and two during dispensing. These results could indicate the primary personnel who 
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identified the error, not necessarily the discipline responsible for where the error 
originated. To summarize, LPNs are the primary personnel involved in the medication 
use process, with almost 80% of the dose omissions occurring during the documenting 
and administering phases combined. Personnel issues (which include basic human error) 
were reported as the cause for 77% of the administering errors. Harm was reported in 
almost one-half of the errors that occurred during the prescribing phase with 39% of the 
prescribing errors being dose omissions. 
  4.2.1.5 Bivariate analysis of primary type of error and facility and resident 
characteristics 
  
 Characteristics of the medication errors by error type are shown in Tables 10 and 
11(Appendix E and Appendix F). A disproportionate percent of errors were reported as 
wrong patient and wrong drug in not-for profit and chain affiliated SNFs when compared 
to the distribution of facilities in the data. Not-for-profit SNFs reported 66.7% of the 
wrong patient and 44.9% of the wrong drug errors, non-chain affiliated SNFs reported 
66.7% of the wrong patient and 51.3% of the wrong drug errors. Younger residents and 
females (85.7%) experienced wrong patient errors more often than older patients nd men 
(14.3%). The average age of residents who experienced a drug administered wrong was 
81.5, with 88.2% of the residents being older than 75. Wrong drug (42.3%) and wrong 
dose (40.2%) were reported more often for residents able to direct their own care. Harm 
was reported more frequently from wrong dose (32.9%) and dose omission (30.1%) 
errors than any other type of error. Wrong dose was reported for 117 medication errors, 
of these 77.8% occurred in for-profit SNFs, 63.3% were affiliated with a chain, 66.7% 
were urban facilities. Although the distribution is similar to the facility characteristics of 
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the data, wrong dose was reported by a greater percent of for-profit SNFs with urban 
locations but fewer SNFs affiliated with a chain. 
  4.2.1.6 Bivariate analysis of primary type of error and error characteristics 
 Descriptive statistics for error characteristics by type of err r are shown in Table 
11. Administering was reported for 81% of the wrong patient errors, 42.3% of the wrong 
drug errors, and 30.8% of the wrong dose medication errors. RNs were reported as the 
primary personnel involved for 47.6% of the wrong patient errors, 19.6% of the wrong 
administration errors, and 26.5% of the wrong dose errors; whereas RNs were report d as 
the primary personnel involved in only 26.5% of the errors reported in the MEQI dataset. 
Three out of the four errors reported by Medication Aides as the primary personn l 
involved were wrong dose errors. Pharmacists were primarily involved in wrong drug 
errors, whereas 38% of the physician errors were reported as other type of error.   In 
summary, not-for-profit SNFs had a disproportionate percentage of wrong person errors, 
for-profit SNFs had a disproportionate percentage of wrong administration errors, chain 
affiliated SNFs had a disproportionate percentage of all errors except wrong personnel. 
Although dose omission errors were the most frequently reported type of error, they 
caused harm in only 10.4% of the errors. Of the residents who experienced a dose 
omission, 63% were unable to direct their own care and took on average 12.5 
medications. Whereas wrong dose errors were reported less often yet they caus d harm in 
20.5% of the reported errors, 40.2% of residents experiencing a wrong dose error were 
unable to direct their own care and took on average more medications (12.9). 
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4.2.2 Multivariate analysis of medication errors by harm 
 The findings from the logistic regression models are shown in Tables 12 and 13. 
Four models were used to evaluate harm caused by medication errors. Both Model 1, 
which does not include the number of medications as an explanatory variable, and Model 
2, which includes the number of medications, are presented as reduced and expanded 
models. In Table 12, reduced Model 1, indicates the odds that a dose omission is 
associated with harm are 58% (OR 0.42; 95% CI 0.22 - 0.82) lower than the odds that a 
wrong dose error is associated with harm, and the odds that a wrong administration eror 
is associated with harm are 73% (OR 0.27; 95% CI 0.07 - 0.98) lower than the odds that a 
wrong dose error is associated with harm as primary error types. Prescribing errors are 
more likely to be associated with harm than administering errors during the medication 
use process (OR 8.6; 95% CI 3.34 - 22.13). Reduced Model 2 in Table 12, indicates the 
odds that a dose omission error is associate with harm are 68% (OR 0.32; 95% CI 0.12 - 
0.85) lower than the odds that a wrong dose error is associated with harm as the primary 
error type. Prescribing errors are more likely to be associated with harm t n 
administering errors during the seven days following admission (OR 7.1; 95% CI 1.18 - 
43.05) (Table 12). 
 
51 
 
 
 
 
  
  
 
Expanded Model 1 in Table 13 indicates prescribing errors are more likely to be 
associated with harm than administering errors during the medication use process (OR 
8.6; 95% CI 2.98 - 24.79), and the odds that a dose omission error is associated with 
harm are 55% (OR 0.45; 95% CI 0.23 - 0.91) lower than the odds that a wrong dose error 
is associated with harm as the primary error type controlling for other variables in the 
model. The odds that a personnel issue is associated with harm are 50% (OR 0.50: 95% 
Model 1 Model 2
Facility Ownership
NFP1 & not Chain affiliated (reference)
NFP & Chain affiliated   0.43 0.11 1.60 0.14 0.02 1.23
FP2 & not Chain affiliated  0.57 0.24 1.32 0.37 0.10 1.30
FP & Chain affiliated  0.90 0.48 1.71 0.49 0.19 1.25
Type of Medication Error
Wrong Dose (reference)
Wrong Patient 0.96 0.27 3.34 1.23 0.11 13.38
Wrong Drug 0.55 0.23 1.32 0.71 0.20 2.50
Dose Omission 0.42 0.22 0.82 0.32 0.12 0.85
Wrong Administration 0.27 0.07 0.98 0.18 0.02 1.54
Wrong Follow-up 0.39 0.12 1.22 0.18 0.03 1.20
Other Type of Error 0.35 0.12 1.02 0.12 0.01 1.16
Medication Use Phase
Administering (reference)
Dispensing 1.16 0.50 2.69 1.18 0.34 4.04
Documenting 0.95 0.50 1.80 1.13 0.43 3.00
Monitoring 2.49 0.41 15.22 9.92 0.49 200.01
Prescribing 8.59 3.34 22.13 7.14 1.18 43.05
Number of medications 1.00 0.92 1.08
Note:  1= Not-for-profit;  2= For-profit. Model 1 does not include number of medications, Model 
2 includes number of medications.
Table 12. Multivariable analysis of the probablity that a medication error is harmful using the 
reduced model
Odds Ratio Estimates
Effect Odds 
Ratio
95% CI Odds 
Ratio
95% CI
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CI 0.29 - 0.96) lower than the odds that a non-personnel issue is associated with harm. 
Factors associated with errors are not mutually exclusive therefore more than one factor 
could be reported and personnel issues could contribute to the other factors. Expanded 
Model 2 in Table 13 contains only 259 observations due to number of medications 
missing for 322 observations, this few observations and the number of variables in the 
expanded model could impact the results. No difference was found in the odds of a 
medication error associated with harm during the administering phase versus any other 
phase of the medication use process.   
  
 
 
Facility Ownership
NFP1 & not Chain affiliated (reference)
NFP & Chain affiliated  0.41 0.10 1.69 0.13 0.01 1.41
FP2 & not Chain affiliated  0.76 0.29 2.02 0.67 0.13 3.39
FP & Chain affiliated 1.02 0.50 2.08 0.76 0.22 2.62
Medication Use Process
Administering (reference)
Dispensing 1.20 0.45 3.21 3.34 0.23 48.87
Documenting 0.97 0.45 2.10 1.72 0.34 8.59
Monitoring 4.17 0.61 28.54 0.34 0.11 1.04
Prescribing 8.59 2.98 24.79 0.13 0.01 1.23
Type of Medication Error
Wrong Dose (reference)
Wrong Patient 0.74 0.18 3.12 0.09 0.01 0.79
Wrong Drug 0.64 0.23 1.77 0.10 0.01 1.07
Dose Omission 0.45 0.23 0.91 1.63 0.37 7.15
Wrong Administration 0.30 0.08 1.17 0.88 0.26 3.00
Wrong Follow-up 0.43 0.14 1.37 32.40 1.16 909.20
Other Type of Error 0.40 0.13 1.26 13.96 1.46 133.13
Table 13. Multivariable analysis of the probability that a medication error is harmful using 
the expanded model
95% CI
Effect Odds 
Ratio 95% CI
Odds 
Ratio
Model 1 Model 2
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Table 13 (continued) 
 
  
Location
Urban (reference)
Non-Urban 1.86 0.98 3.55 2.27 0.75 6.85
Number of Beds
<100 (reference)
101-150 0.69 0.36 1.31 1.19 0.40 3.50
>151 0.49 0.22 1.07 1.04 0.25 4.30
Gender
Female 0.84 0.47 1.51 0.43 0.15 1.24
Age 0.98 0.96 1.00 1.06 1.00 1.12
Patient able to direct own care
No 1.11 0.62 1.99 0.98 0.36 2.69
Personnel involved
LPN 
all other non LPN 0.68 0.39 1.20 2.02 0.74 5.57
Causes of Errors
Product issue 1.42 0.42 4.83 0.21 0.01 3.98
Recording issue 0.78 0.36 1.71 1.52 0.40 5.84
Dispensing 0.51 0.17 1.49 0.53 0.09 3.13
Facility issue 1.94 0.91 4.13 2.18 0.61 7.86
Personnel issue 0.50 0.26 0.96 0.41 0.14 1.20
Other causes 1.40 0.46 4.24 1.75 0.22 13.89
Number of medications 1.02 0.93 1.13
Note:  1= Not-for-profit;  2= For-profit. Model 1 does not include number of medications, 
Model 2 includes number of medications.
 
 
 
 
CHAPTER 5: DISCUSSION 
 
 
5.1 Discussion 
This study is the first to explore the relationships between and inter-relatedness of 
specific SPO elements contributing to harmful medication errors for those per ons 
transitioning into SNFs. Understanding these elements and the inter-relationships 
between structure and process factors will contribute to improvements in systematic 
processes of the medication use process as residents transition into SNFs. Reducing 
medication errors and adverse drug events through process changes will contribute to 
improved resident safety. Bivariate, multivariable, and regression statistics were used to 
examine the relationships for 581 medication errors that were reported by North Carolina 
SNFs from October 1, 2006 - September 30, 2007, and occurred during the first seven 
days of admission into the nursing home. 
 This study contained medication errors from 138 SNFs which is approximately 
one third of the SNFs in North Carolina. The percent of for-profit SNFs in the data was 
less than the percent of for-profit SNFs in North Carolina (Table 1), yet ther were more 
for-profit chain affiliated SNFs reporting errors during the first seven days of admission. 
This could be because more errors occurred during this time period in these faciliti s or 
for-profit non chain affiliated SNFs are less likely to report medication errors. In contrast, 
not-for-profit chain affiliated SNFs were underrepresented with the smallest number of 
facilities reporting errors during the first seven days of admission. A for-profit SNF that 
is a member of a chain is more likely to report an error than a not-for-profit SNF hat is a 
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member of a chain, indicating profit status is associated with reporting medication errors 
when controlling for the interaction of chain membership. 
 Using a structure variable such as profit status or number of beds has been shown 
in previous studies to contribute to the study of quality in nursing homes. In this study 
profit status was shown to interact with chain affiliation, but was not associated with a 
harmful medication error. Further study of the interaction of profit status and chain 
affiliation could contribute to understanding the effect of ownership status and work 
processes that contribute to quality outcomes for long-term care residents. Location had 
no effect on the number of medication errors reported by the facility. Facility size was 
associated with reporting of medication errors, larger facilities reported more errors. This 
is consistent with previous findings related to quality and facility size. Although larger 
facilities have been reported to have more deficiencies this could be due to the increased 
number of residents and opportunities for errors, not necessarily a higher rate of errors 
per resident or per bed. In addition, other factors related to the reporting of errors such as 
reporting protocols, or increased awareness of near miss incidents have not been 
accounted for and could contribute to reporting more errors. As in this study, where a 
larger facility (>151 beds) is two times more likely to report a medication error than a 
smaller (<100 beds) facility, may not indicate a higher rate of errors per resident. 
 Errors reported during the seven day transition period into the SNF were more 
prevalent during the documentation phase of the medication use process than the 
administering phase. In contrast, when all MEQI errors are considered, administration 
errors were the most frequently reported. This indicates that error detection during the 
first seven days of admission may be related to admission documentation and the 
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transcribing of orders for new residents, rather than the process of medication 
administration. Prescribing errors although reported less frequently were the most 
harmful, similar to the entire MEQI year where 23% of the prescribing errors caused 
harm. These findings indicate an opportunity to improve resident safety, further study of 
the prescribing process to include disciplines involved in identification of a prescribing 
error will contribute to a safer medication use process. 
The medication use process is comprised of five steps each contributing to the 
provision of safe, effective, and optimal pharmaceutical care. Documenting (trascribing) 
is the process of transferring the physician orders from document to document, or to 
document the completion of a task. During admission into the SNF documenting of 
orders is often a part of the admissions process, where the medication list is transferred 
from the discharging facility's forms onto the SNF medication administration record. 
Errors occurring or identified during the documentation phase of the medication use 
process may not reach the resident and therefore incur fewer harmful outcomes han other 
phases of the medication use process. In this study more of the administering errors 
caused harm than documenting errors. Reported potential and probable causes for errors 
indicate that recording errors (which includes transcription errors) occurred five times 
more often during documentation than the administration phase of the medication use 
process. This is possibly due to errors being identified earlier in the process (during 
transcription) preventing errors later (during administering) in the sequence.  
This study did not support Hypothesis 1a. For-profit SNFs did not have 
significantly more medication errors during the seven days following admission than not-
for-profit SNFs. However, not-for-profit SNFs were overrepresented and for-profit SNFs 
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were underrepresented in the study when compared to the SNFs in North Carolina. Yet 
when accounting for the interaction of being affiliated with a chain, this study indicates 
that for-profit SNFs affiliated with a chain reported close to four times more edication 
errors than for-profit SNFs not affiliated with a chain. And in the study, not-for-profit 
chain affiliated SNFs reported fewer medication errors than not-for-profit non chain 
affiliated SNFs. The interaction of being a member of a chain and profit status appears to 
impact the risk of medication errors during the seven days following admission into the 
SNF. Not-for-profit SNFs who were members of a chain are less likely to report 
medication errors than for-profit SNFs who were not members of chains. Chain
membership appears to have a protective effect, as for-profit SNFs who were memb rs of 
chains had fewer medication errors than for-profit SNFs who were not members of 
chains, possibly due to standardized procedures (Table 4).  
 Model 2 which controlled for bed size and location did not support previous 
findings on ownership status but did support previous findings on facility size and 
quality. Our study indicates that SNFs with greater than 151 beds are two times more 
likely to report a medication error during transition than a SNF with fewer than 100 beds. 
Previous findings indicate larger facilities provide lower quality care such as increased 
use of restraints and number of deficiencies. Although as indicated above this could be 
due more to increased opportunities by volume than actual error rates per resid nt. 
The findings in this study did not support Hypothesis 1b:  A harmful medication 
error is more likely to be reported by a for-profit nursing home than not-for-profit nursing 
home during the seven days following admission. This is inconsistent with previous 
studies of structure and quality that report for-profit nursing homes provide lower quality 
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of care than not-for-profit facilities. This difference could be due to the variables used in 
the analysis. Harrington et al. used deficiencies from state inspections obtained through 
the national OSCAR database19; O'Neill et al. used deficiencies from California nursing 
homes from the OSCAR and California licensing reports21; and Amirkhanyan et al. used 
the OSCAR database and Nursing Home Compare website103. A variety of quality 
indicators can be found in the OSCAR database (i.e. decubiti, restraint use, weight loss, 
abuse, staffing, etc.) medication errors and their causes are not a component of th  
OSCAR database. The medication errors in this study were self-reported whereas the 
OSCAR database is comprised of observed deficiencies and facility annual required 
reporting elements. Another difference could come from whether the facility actually had 
a medication error and did not report it. For example, if a nurse identified a wrong dose 
on a new admission's medication list she might obtain a correct order from the provider, 
make the change on the chart and not report this as a potential medication error. Nurses' 
perceptions of medication errors have been shown to impact reporting76, 118.   
The policy and processes for reporting of errors varies between facilities and 
organizations. A group of facilities under the same chain ownership could all followone 
set of processes; a facility not affiliated with a chain could have a different set of 
processes. Thus all the facilities belonging to the chain will follow the sameidentifying 
and reporting processes in the reporting of errors. The ownership philosophy on residet 
safety and identification of actual and potential medication errors contributes to reporting 
methods and frequencies. The data in this study were facility reported potential or actual 
errors, the percent of for-profit-SNFs reporting errors during the first seven days of 
admission is similar to the percent of for-profit-SNFs in North Carolina. Further study of 
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the processes of reporting errors between ownership and chain affiliation will contribute 
to improved practices in resident safety.  
These results could be due to the small sample size of 581 medication errors and 
137 SNFs and a power analysis that proposed for-profit SNFs would have two times 
more medication errors than not-for-profit SNFs at an alpha level of .05. 
 The findings of the study did not support Hypothesis 2: Medication errors are 
more likely to be harmful when administering is reported as the medication use phase 
compared to any other phase in the medication use process during the seven days 
following admission. Although one-third of the errors reported were during the 
administration phase and 11.3% caused harm, a greater percentage of errors that caused 
harm occurred during the prescribing and dispensing phases of the medication use 
process. Regression analysis indicates errors that occur during prescribing a e more likely 
to cause harm than errors during the administering phase. Santell and Hicks in their study 
of hospitalized older adults reported that out of 80,169 medication errors 6% were 
prescribing errors and 10% of the prescribing errors were harmful31. In Gurwitz et al. 
study of adverse drug events in two academic long term care facilities preventable 
adverse drug events (errors) occurred most often (59%) in the ordering (prescribing) 
phase and only 13% in the administering phase. Both studies indicate similar findings; 
although the volume of reported errors is lower, the harm occurring during prescribing is 
often greater than during administration. One study of medication error reporting 
indicates the likelihood of an error being reported increases during the administration 
phase and when the error was not prevented from reaching the patient. Most errors were 
prevented from reaching the patient and not reported indicating fewer reports of errors 
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during the prescribing phase because they were corrected118. Further research in this area 
would support identifying systems to prevent prescribing errors reaching the resident. A 
system which has received attention for the prevention of adverse drug events is 
computer physician order entry (CPOE). Evaluation of CPOE in relation to prescribing 
errors will contribute to the use of CPOE and potentially electronic medical record 
(EMR) systems. Use of mandatory CPOE and EMR has broad reaching policy 
implications for SNFs as their use is limited at this time. 
 Basic human error was reported as a cause of the error for over one half of t e 
errors in the data set. This could be due to: the ability to select more than one cause, basic 
human error could contribute to other error causes, or it could be used as a 'catch all' 
category. Basic human error as defined by the MEQI-IE reporting form is: simple 
mistake, forgot, orders overlooked, carelessness or oversight. The individual completing 
the form could select basic human error to conceal the real cause or as a means to not 
assign blame. Errors could be the result of a simple mistake which occurred due to poor 
lighting, environmental distractions, workload, or not being aware of facility policies. 
Further analysis of the cause category will contribute to better understanding of the 
causes and perceptions of the causes of errors. Assessing the additional causes selected in 
coordination with basic human error will contribute to an understanding of the 
contributing factors and their relationships. Exploring the written comments and 
responses submitted under the 'other' category will also contribute to this knowledge. 
 The findings of the study support Hypothesis 3: Medication errors are more likely 
to be harmful when wrong dose is reported as the error type compared to any other tpe 
of error during the seven days following admission. Wrong dose errors were the most 
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likely error type to cause harm. Dose omissions were less likely to cause harm than 
wrong dose errors when controlling for ownership and the medication use process. 
Similar findings were reported by Santell with 5% of the improper dose/quantity type of 
errors and 2% of the dose omissions reported as harmful in his study of hospitalized older 
adults31.  Leape et al. reported wrong dose and wrong choice (choice of drug or dose 
inappropriate) errors caused injury in 42% of the adverse drug events in their study of 
eleven medical and surgical units66. This same study reported that almost half of the 
wrong dose errors occurred at the physician ordering phase and 70% were intercepted, 
whereas only two wrong dose errors that occurred in the nurse administration phase were 
intercepted. Further research evaluating wrong dose errors will contribute to reducing 
harmful medication errors through changes in the ordering and administering processes. 
Research evaluating wrong dose errors and their origination in the medication use process 
(e.g. wrong dose ordered, wrong dose administered due to packaging, wrong dose 
calculated, wrong dose due to illegible handwriting) will provide opportunities to modify 
medication processes. Potential policy implications include designating packaging 
specifications for medications to prevent wrong dose dispensing.  
 Of the errors medication aides were involved in wrong dose was reported for 
three of the four. As the use of medication aides continues to grow further research into 
the types and causes of errors where medication aides are the primary personnel inv lved 
will contribute to understanding their benefit in staffing of SNFs. In this study the use of 
medication aides was relatively new for North Carolina SNFs. Future research will 
contribute to understanding whether only four errors being reported indicates a sf r
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medication administration by medication aides, or just fewer SNFs using medication 
aides at the time of this research.   
5.2 Study Limitations 
 North Carolina requires a mandatory self reporting of medication errors for SNFs. 
The IOM in its 1999 report34 presents the incongruous nature of reporting systems, where 
they are intended for both learning from the incident and addressing accountability. 
Mandatory reporting of errors has been implemented as an effort to address 
accountability and has raised strong objections due to fear of damaged reputations and 
increased legal liability75. Voluntary reporting systems are used to study medication 
errors (a learning activity) as a means to prevent and reduce errors and potentially harm. 
Mandatory reporting does not ensure that all actual and potential medication errors are 
reported. Reports indicate compliance with mandatory programs has been inconsistent 
and that practitioners perceive mandatory programs as assigning blame rather th n 
identifying system-based causes that could lead to process correction. Of the 203 NC 
SNFs reporting medication errors in the MEQI-IE system during FY 2007 only 137 were 
used in the facility level analysis in this study, indicating the remaining facilities did not 
report medication errors within the first seven days or incomplete information was 
submitted.  
 One of the most significant limitations to the study was that the medication err rs
in the dataset were self reported medication errors. Medication errors can be detected by 
various methods including observation, incident reporting, and medical record review. 
Each presents strengths and weaknesses in identifying medication errors. Studies of error 
collection methods indicate observation is the most valid and cost effective15. 
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Observation entails the observation of preparation and administration of medication to 
the patient. One study reported that of the 318 medication errors reported through 
observation only one was detected by an error report67. Underreporting of medication 
errors is a significant barrier to improving safety; studies indicate that nurses believe that 
only 3.5% of medication errors are ever reported due to fear of disciplinary action, shame 
and job loss69.  
 The data used in this analysis was for only one reporting year and only the data 
collected through the MEQI-IE, individual error reporting system, which represents about 
one half of the errors reported to the Sheps center during the study year. The errors 
reported in the MEQI-AR, annual report system were not available for the study. The 
published summary results state there were 190 facilities that used the annual report 
system with an average of 41 errors per facility and 34 errors per 100 beds, wh reas those 
using the individual error had an average of 28 errors and 23 errors per 100 beds. Harm 
occurred in 8.2% of the errors reported in the annual report system, whereas harm 
occurred in 10.5% of the errors reported by facilities using the individual error system. In 
general, residents in facilities using the annual report reporting system were older, more 
were women and could not direct their own care. SNFs reporting using annual report 
system reported 53% of the errors as dose omissions, facilities using individual error 
system reported that 41% were dose omissions9. Facilities that chose the annual report 
system may have different error incidences than facilities who submitted reports through 
the individual error system. These differences are not known. The number of errors 
occurring during the seven days following admission into the SNF is also unknown for 
those facilities using the annual report system. In year five, the number of SNFs using the 
64 
 
 
 
individual error reporting system increased to 73% and beginning October of 2008, all 
SNFs were required to report using the individual error system, eliminating these 
unknown differences111.  
 Limited facility and resident characteristics were available for analysis. Resident 
acuity levels are not known. Only age, gender, and cognitive ability and impact according 
to the NCC-MERP index are known. Therefore two residents may experience the same 
medication error but have different outcomes due to their physiological status, where 
resident acuity is not accounted for when dichotomizing into harm or no harm. 
Limitations of the models include potential omitted variable bias and unexplained 
error. The data was self reported from a mandatory reporting program. MEQI data is only 
from the state of North Carolina during 2007, and contains limited resident and facility
characteristics. The data is limited to medication errors during the transition period into 
the SNF, and the dataset could not be merged with any other data under the data use 
agreement.  
5.3 Conclusions 
 This study supports the need for improved processes as patients transition 
between providers, with 68% of the SNFs reporting a medication error during the first 
seven days of a resident's admission. Further research in error reporting methods and 
cultures of reporting will improve the data collected and opportunities for safer resident 
care. The punitive culture of the nursing home environment does not likely support a 
transparent environment or one of open communication. Fear of litigation, survey 
deficiencies, and civil monetary penalties could contribute to under-reporting of errors.  
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 The interaction between SNF ownership and chain affiliation deserves further 
study. Does the membership in a chain provide an increase in effectiveness by access to 
performance improvement programs, standardized processes, and resources, or merely 
more efficiency and profit? Is the impact of a chain different for not-for-pr fit and for-
profit SNFs? In this study the relationship between being of a chain, regardless of profit 
status, had a protective effect from a resident experiencing a medication error. Further 
research evaluating the systems and processes used by multi-facility operations will 
contribute to an understanding of the processes that improve resident safety. Examples of 
systems and processes include: evaluation of systems such as corporate oversight and 
their evaluation of individual SNF operations, policy development at the corporate level 
with mandatory implementation at the facility level, use of economies of scale, and the 
use of resources to investigate and review errors and potential errors. 
 The medication use process is complex with multiple opportunities for error 
occurrence. The method of error detection and the persons involved often determine 
when an error is identified and the response. Additional study of both the phases where 
large numbers of errors occur (documenting and administering) along with studies of 
phases where the most harm occurs (prescribing) will identify processes contributing to 
harmful outcomes. Previous research indicates that observation of medication 
administration identifies considerably more errors than chart review and incident 
reporting. Further study of the relationship between the primary personnel involved in the 
study and phases of the medication use process will contribute to understanding reporting 
processes and where the error originates. As this study shows physicians were only 
involved with 39.3% of the prescribing errors. If the error is truly a prescribing error then 
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it should originate with the physician not the nurse. The same could be said for a 
dispensing error which should originate with the pharmacist.  
 This study did not indicate a relationship between the processes of administering 
medications and a harmful medication error. The process of prescribing medications was 
found to contribute to harmful medication errors. Donabedian's model where process 
contributes to outcome was supported with the medication use process of prescribing 
medications contributing to harmful medication errors.  
 Wrong dose errors contributed to considerable harm in this study. Further 
research in the prevention of wrong dose errors (under dose and overdose) will contribute 
to improved medication therapies for SNF residents. Evaluation of wrong dose causes
(packaging, communication between providers, distractions, etc) will contribute to a 
better understanding and improved medication administering process. We reported 
almost two-thirds of the wrong dose errors were due to personnel issues, with basic 
human error being the most prevalent cause. Further defining basic human error into 
specific human errors will contribute to reducing medication errors and a safer resident 
care environment. Almost half of the wrong dose errors occurred during the documenting 
phase with 42.7% a recording issue. Further evaluation, such as observation of when and 
how documenting and recording of medications at admission occurs will contribute to a 
better understanding of how these processes contribute to safer resident outcomes. 
Implementing practices that rely on systematic processes, such as preprinted forms and 
checklists, instead of human memory for specific processes such as admission 
documentation will contribute to improved resident outcomes. 
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 Potential policy implications include improved communication between providers 
across the continuum of care. Our study indicated 68% of the SNFs reported an error 
within the first seven days of the resident's admission to the facility; supporting the eed 
for medication reconciliation at admission into the SNF. At the time of this study North
Carolina did not have a requirement for SNFs to complete medication reconciliation for 
new admissions. Although JCAHO does mandate medication reconciliation across the 
continuum it is difficult to mandate reconciliation when many SNFs are not JCAHO 
accredited. 
 At the time of this study few nursing facilities in North Carolina used electronic 
health records and related information technology in documenting resident care 
processes. As the uses of information technology continue to indicate reduction in 
medication errors and adverse drug events in acute care, potential policy impliations for 
SNFs include use of automated processes for physician orders and the prescribing 
process, on-line decision support systems and alert and warning systems for allergies and 
drug interactions.  
 As information on the use of medication aides becomes more prevalent, further 
study of their impact on the safe administration of medications should be evaluated. 
Studies with larger sample sizes will contribute to understanding their contribution to a 
safe medication use process and potentially relieving the expected shortage of nurses as 
the demographics change. The outcomes of these studies will have policy implications 
for the future of the nursing workforce and processes used to staff SNFs. 
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